Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Biol Pharm Bull ; 40(4): 535-539, 2017.
Article in English | MEDLINE | ID: mdl-28381809

ABSTRACT

Pigmentation reflects skin darkening caused by melanin production, but excessive melanin synthesis may cause problems, such as melasma, solar lentigo, dark spots, and freckles. Considerable effort has been devoted to alleviating these undesired symptoms through the development of safe and effective depigmenting agents. Coumestrol, a plant-derived natural isoflavone with an estrogen-like structure and actions, is known to have anti-aging ability, but its potential depigmenting efficacy has not been evaluated. In the present study, we investigated the effects of coumestrol on melanin synthesis in normal melan-a murine melanocytes. Coumestrol significantly reduced melanin synthesis in a concentration-dependent manner up to a concentration of 25 µM without causing cytotoxicity. It also brightened tissue in an artificial skin model (MelanoDerm) that incorporates both human keratinocytes and melanocytes. Interestingly, although coumestrol did not inhibit tyrosinase activity or transcript level in melan-a cells, it clearly decreased the expression level of tyrosinase protein at a concentration of 25 µM. This coumestrol-induced reduction in tyrosinase protein levels was prevented by pretreatment with the proteasome inhibitor MG-132 or the lysosomal proteolysis inhibitor chloroquine. Collectively, our findings indicate that coumestrol exerts an inhibitory effect on melanin synthesis in melan-a cells, at least in part, through degradation of tyrosinase. These findings suggest that coumestrol is a good candidate for use in depigmentary reagents from a cosmetic and clinical perspective.


Subject(s)
Coumestrol/pharmacology , Down-Regulation/drug effects , Melanins/antagonists & inhibitors , Melanocytes/drug effects , Monophenol Monooxygenase/metabolism , Animals , Cell Line, Transformed , Cell Survival/drug effects , Cell Survival/physiology , Cysteine Proteinase Inhibitors/pharmacology , Down-Regulation/physiology , Leupeptins/pharmacology , Melanins/biosynthesis , Melanocytes/metabolism , Mice , Mice, Inbred C57BL , Phytoestrogens/pharmacology
2.
Int J Mol Sci ; 14(1): 1655-66, 2013 Jan 15.
Article in English | MEDLINE | ID: mdl-23322017

ABSTRACT

The development of melanogenic inhibitors is important for the prevention of hyperpigmentation, and, recently, consideration has been given to natural materials or traditionally used ingredients such as Chinese medicine. The aim of this study is the evaluation of a new anti-melanogenic candidate, kadsuralignan F, from the natural plant Kadsura coccinea, as well as the determination of mechanisms of melanogenesis inhibition at a molecular level. Kadsuralignan F significantly reduced melanin synthesis in a dose-dependent manner in a murine melanocyte cell line and human skin equivalents. There was no direct inhibition on mushroom tyrosinase or cell-extract tyrosinase activity, and mRNA expression of tyrosinase and other melanogenic genes such as tyrosinase-related protein-1 (trp-1) or trp-2 were not affected by kadsuralignan F. Interestingly, the protein level of tyrosinase was dramatically downregulated with kadsuralignan F treatment. We found that a decrease of tyrosinase protein by kadsuralignan F was fully recovered by MG132, a proteasome inhibitor, but not by chloroquine, a lysosome inhibitor. In this study, we found that kadsuralignan F, a lignan from an extract of Kadsura coccinea, has an inhibitory activity on melanin synthesis through tyrosinase degradation. These findings suggest that kadsuralignan F can be used as an active ingredient for hyperpigmentation treatment.


Subject(s)
Cyclooctanes/pharmacology , Lignans/pharmacology , Melanins/biosynthesis , Melanocytes/drug effects , Skin/drug effects , Animals , Blotting, Western , Cell Line , Cell Proliferation/drug effects , Cell Survival/drug effects , Cyclooctanes/chemistry , Dose-Response Relationship, Drug , Down-Regulation/drug effects , Gene Expression/drug effects , Humans , Intramolecular Oxidoreductases/genetics , Intramolecular Oxidoreductases/metabolism , Kadsura/chemistry , Lignans/chemistry , Melanocytes/cytology , Melanocytes/metabolism , Mice , Molecular Structure , Monophenol Monooxygenase/genetics , Monophenol Monooxygenase/metabolism , Oxidoreductases/genetics , Oxidoreductases/metabolism , Plant Preparations/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Skin/metabolism , Skin Pigmentation/drug effects
3.
Article in English | MEDLINE | ID: mdl-21912567

ABSTRACT

Topical retinoids inhibit matrix metalloproteinases and accelerate collagen synthesis, thereby triggering antiaging effects in the skin. However, topical retinoids can cause severe skin reactions, including scaling, erythema, papules, and inflammation. The present study demonstrates that the ethanolic bark extract of Alstonia scholaris R. Br. can significantly inhibit all-trans retinoic acid-induced inflammation in human HaCat keratinocyte cells. Furthermore, two representative retinoid-induced proinflammatory cytokines, monocyte chemoattractant protein-1 and interleukin-8, were significantly suppressed by A. scholaris extract (by 82.1% and 26.3% at 100 ppm, and dose-dependently across the tested concentrations) in vitro. In a cumulative irritation patch test, A. scholaris extract decreased retinol-induced skin irritation, while strengthening the ability of retinoids to inhibit matrix metalloproteinase-1 expression, which is strongly associated with aging effects. These results suggest that A. scholaris is a promising compound that may increase the antiaging function of retinoids while reducing their ability to cause skin irritation.

4.
Phytother Res ; 26(8): 1107-12, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22162275

ABSTRACT

In this study we investigated the inhibitory effects and possible mechanisms of action of 8'-hydroxydaidzein and 3'-hydroxydaidzein, two ortho-dihydroxyisoflavone derivatives from Korean fermented soybean paste, on melanogenesis in B16 murine melanoma cells. The two hydroxydaidzeins reduced melanin synthesis comparably to treatment with kojic acid, a proven whitening agent, in B16 melanoma cells. Furthermore, when in vitro human skin equivalents were treated with the hydroxydaidzeins, the levels of melanogenesis were significantly reduced relative to a kojic acid control. The RT-PCR results demonstrated that depigmentation was due to transcriptional repression of several melanogenesis genes, including microphthalmia-associated transcription factor (MITF), by the hydroxydaidzeins. The immunoblotting results confirmed that diminution of MITF expression subsequently decreased expression of tyrosinase, and tyrosinase-related proteins 1 and 2. Cumulatively, these results suggest that hydroxydaidzeins would be potent attenuators of melanin synthesis as well as effective inhibitors of hyperpigmentation in human skin.


Subject(s)
Gene Expression Regulation, Neoplastic , Glycine max/chemistry , Isoflavones/pharmacology , Melanins/biosynthesis , Melanoma, Experimental/pathology , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Cell Proliferation/drug effects , Cell Survival , Enzyme Activation , Fermentation , Humans , Hyperpigmentation/metabolism , Hyperpigmentation/pathology , Melanins/metabolism , Mice , Microphthalmia-Associated Transcription Factor/genetics , Microphthalmia-Associated Transcription Factor/metabolism , Oxidoreductases/genetics , Oxidoreductases/metabolism , Pyrones/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Skin/drug effects , Skin/metabolism , Skin/pathology , Transcription, Genetic
5.
Bioorg Med Chem Lett ; 21(21): 6482-4, 2011 Nov 01.
Article in English | MEDLINE | ID: mdl-21917453

ABSTRACT

Lamin A-dependent nuclear aberration and DNA damage was found in premature aging disease or normally old individuals. In this study, UVB irradiation was used as a cellular senescence inducer, and it was found that Lamin A and phospho-H2AX protein was increased by UVB treatment on normal human fibroblast. Lamin A-dependent morphological nuclear defect was observed in UVB treated fibroblast. Amentoflavone, a well known biflavonoid, inhibited the increase of Lamin A or phospho-H2AX protein in dose dependent manner which was induced by UVB irradiation, and also protected nuclear aberration dramatically. These results indicated that amentoflavone is an anti-aging candidate for UVB related skin aging process.


Subject(s)
Biflavonoids/pharmacology , Cell Nucleus/drug effects , Lamin Type A/metabolism , Ultraviolet Rays , Cell Nucleus/metabolism , Cell Nucleus/radiation effects , Fibroblasts/drug effects , Fibroblasts/metabolism , Fibroblasts/radiation effects , Humans
6.
Int Immunopharmacol ; 4(9): 1187-99, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15251114

ABSTRACT

Though lactoferrin (LF) is a glycoprotein that is involved in immunomodulation, its action mechanism has not been fully elucidated. Previous studies have suggested that lipopolysaccharide (LPS) activity is inhibited by direct binding between LPS and LF. However, here we show that when LPS and purified LF was mixed, and formed a complex (termed as LF-LPS), it was found to induce production of inflammatory mediators in macrophages to some extent, rather than inhibit LPS activity. Moreover, when macrophages were pretreated with LF-LPS, cells were rendered a tolerant state to LPS challenge. These macrophage-activating effects were mediated by Toll-like receptor 4 (TLR4)-NF-kappaB pathway. Comparative studies with C3H/HeN and C3H/HeJ mice demonstrated the strong dependency of the LF-LPS signal on TLR4. These findings suggest that the immunomodulatory properties of LF could be due, in part, to LPS binding.


Subject(s)
Acute-Phase Proteins/pharmacology , Carrier Proteins/pharmacology , Inflammation/pathology , Lactoferrin/pharmacology , Macrophage Activation/drug effects , Membrane Glycoproteins/pharmacology , Animals , Blotting, Western , Cells, Cultured , Electrophoretic Mobility Shift Assay , Immunoassay , Lipopolysaccharides/pharmacology , Membrane Glycoproteins/drug effects , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred C3H , NF-kappa B/metabolism , Nitrites/analysis , Nitrites/metabolism , Receptors, Cell Surface/drug effects , Receptors, Cell Surface/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Toll-Like Receptor 4 , Toll-Like Receptors , Tumor Necrosis Factor-alpha/biosynthesis
7.
Toxicology ; 200(2-3): 235-46, 2004 Aug 05.
Article in English | MEDLINE | ID: mdl-15212819

ABSTRACT

Our previous results describing the CH12.LX (AhR-expressing) and BCL-1 (AhR-deficient) B cell lines have supported an AhR/dioxin-responsive element (DRE)-mediated mechanism for TCDD-induced inhibition of micro heavy chain expression and thus of IgM secretion. Transcriptional regulation of the Ig heavy chain genes involves several regulatory elements including the 3'alpha Ig heavy chain enhancer, which is composed of four regulatory domains that span approximately 40 kb. One of these domains, hs4, contains a DRE-like site that overlaps a kappaB motif. We have previously demonstrated TCDD-inducible binding of both the AhR nuclear complex and NF-kappaB/Rel proteins to the DRE and kappaB motifs, respectively, as well as TCDD and LPS-induced transcriptional activity through the hs4 domain. The objective of the present study was to determine if the AhR nuclear complex and NF-kappaB/Rel proteins converge at these two overlapping cis-elements and act cooperatively to influence enhancer activity. To eliminate the potential influence of other transcription factors which bind to the hs4 domain, the approach was to construct a series of luciferase reporters containing a variable heavy chain (VH) promoter and a 42 bp fragment of the 1.4 kb hs4 regulatory domain, that included only the overlapping DRE and kappaB motif or mutations of these motifs for transient transfection experiments in CH12.LX and BCL-1 cells. In the CH12.LX cells, TCDD activated the hs4 fragment; however, co-treatment with LPS led to a marked and synergistic activation as previously observed with the wild type 1.4 kb hs4 domain. Mutation of either or both of the DRE and kappaB motifs diminished the effect of TCDD and LPS on the luciferase reporters possessing the 42 bp portion of hs4, and resembled the effect of these treatments on the promoter alone. In the BCL-1 cells, activity of the hs4 fragment was not induced by TCDD and/or LPS treatment. These results suggest that the AhR nuclear complex and NF-kappaB/Rel proteins converge at the DRE and kappaB motif to influence transcriptional activity of the hs4 enhancer fragment.


Subject(s)
Dioxins/toxicity , Environmental Pollutants/toxicity , Immunoglobulin alpha-Chains/metabolism , NF-kappa B/drug effects , Response Elements/drug effects , Animals , Cell Line , Genes, bcl-1/genetics , Indicators and Reagents , Luciferases/analysis , Mice , Mutation/genetics , Polychlorinated Dibenzodioxins/toxicity , Promoter Regions, Genetic , Receptors, Aryl Hydrocarbon/drug effects , Transfection
8.
Pigment Cell Melanoma Res ; 27(6): 1051-62, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25065405

ABSTRACT

Mitochondrial dynamics control mitochondrial functions as well as their morphology. However, the role of mitochondrial dynamics in melanogenesis is largely unknown. Here, we show that mitochondrial dynamics regulate melanogenesis by modulating the ROS-ERK signaling pathway. Genetic and chemical inhibition of Drp1, a mitochondrial fission protein, increased melanin production and mitochondrial elongation in melanocytes and melanoma cells. In contrast, down-regulation of OPA1, a mitochondria fusion regulator, suppressed melanogensis but induced massive mitochondrial fragmentation in hyperpigmented cells. Consistently, treatment with CCCP, a mitochondrial fission chemical inducer, also efficiently repressed melanogenesis. Furthermore, we found that ROS production and ERK phosphorylation were increased in cells with fragmented mitochondria. And inhibition of ROS or ERK suppressed the antimelanogenic effect of mitochondrial fission in α-MSH-treated cells. In addition, the activation of ROS-ERK pathway by mitochondrial fission induced phosphorylation of serine73 on MITF accelerating its proteasomal degradation. In conclusion, mitochondrial dynamics may regulate melanogenesis by modulating ROS-ERK signaling pathway.


Subject(s)
Extracellular Signal-Regulated MAP Kinases/metabolism , Melanins/biosynthesis , Microphthalmia-Associated Transcription Factor/metabolism , Mitochondrial Dynamics , Proteasome Endopeptidase Complex/metabolism , Proteolysis , Reactive Oxygen Species/metabolism , Animals , Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology , Cell Line, Tumor , Down-Regulation/drug effects , Dynamins/metabolism , Epidermal Cells , Humans , Melanocytes/drug effects , Melanocytes/enzymology , Melanoma, Experimental/metabolism , Melanoma, Experimental/pathology , Mice, Inbred C57BL , Mitochondrial Dynamics/drug effects , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinase Kinases/metabolism , Proteolysis/drug effects , Quinazolinones/pharmacology , alpha-MSH/pharmacology
9.
J Dermatol ; 40(11): 919-22, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24580132

ABSTRACT

Transient receptor potential melastatin 8 (TRPM8) is a member of the TRP family, and is activated at temperatures below 22°C, or by cooling compounds such as menthol. In this study, it was found that a new role of TRPM8 activation on prostaglandin E2 (PGE2), an inflammatory cytokine and dendritogenesis stimulator of normal human melanocytes. Normal human keratinocytes were pretreated with menthol or incubated at 22°C for TRPM8 activation before ultraviolet (UV)-B irradiation. To examine the specificity between TRPM8 activation and PGE2 release, we inhibited TRPM8 with the antagonist (capsazepine), or introduced TRPM8 siRNA for a gene silencing experiment. UV-B irradiation significantly induced PGE2 release in normal human keratinocytes. Interestingly, activation of TRPM8 at 22°C or with menthol inhibited UV-B-induced PGE2 release. The effect of the TRPM8 agonist was completely blocked by pretreatment with the TRPM8 antagonist, capsazepine. When TRPM8 expression was suppressed by siRNA, UV-B irradiation still upregulated PGE2 in keratinocytes, but pretreatment of menthol or low temperature did not inhibit UV-B-induced PGE2. In conclusion, the activation of TRPM8 inhibits UV-B-induced PGE2 production in keratinocytes, and the activation of TRPM8 may reduce inflammatory responses in skin.


Subject(s)
Dinoprostone/biosynthesis , Keratinocytes/radiation effects , TRPM Cation Channels/metabolism , Cells, Cultured , Humans , Keratinocytes/metabolism , Ultraviolet Rays
10.
Nat Prod Commun ; 8(11): 1605-8, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24427952

ABSTRACT

Overproduction of melanin is the cause of skin hyperpigmentation, which is related to several skin diseases and cosmetic concerns. Sake is a Japanese alcoholic beverage produced from rice and water by fermentation, but is little known for its effect on melanogenesis. To identify the effect of sake extract on melanin synthesis, a melanin assay was performed in melan-A murine melanocytes. Sake extract treatment significantly inhibited melanin production in a dose-dependent manner, and tyrosinase, the rate-limiting enzyme of melanogenesis, decreased significantly at the protein level. Further investigations were performed with multiple assay systems; a sake extract reduced melanin production in melan-A/SP-1 murine cell co-culture, and also in MelanoDerm, a skin equivalent model of human keratinocytes-melanocytes. Finally, subjects were treated with a formula containing the sake extract. Topical application of the sake extract product improved skin lightness (L*) significantly within 7 days. We identified sake extract as a new anti-melanogenic ingredient through in vitro and in vivo experiments. These results suggest that a sake extract can be used to improve skin hyperpigmentation.


Subject(s)
Alcoholic Beverages , Melanins/antagonists & inhibitors , Skin Pigmentation/drug effects , Adult , Cells, Cultured , Clinical Trials as Topic , Female , Humans , Melanins/biosynthesis , Middle Aged
11.
Biochem Pharmacol ; 74(5): 780-6, 2007 Sep 01.
Article in English | MEDLINE | ID: mdl-17658483

ABSTRACT

It is well known that c-kit is related to pigmentation as well as to the oncology target protein. The objective of this study was to discover a skin-whitening agent that regulates c-kit activity. We have developed a high-throughput screening system using recombinant human c-kit protein. Approximately 10,000 synthetic compounds were screened for their effect on c-kit activity. Phenyl-imidazole sulfonamide derivatives showed inhibitory activity on c-kit phosphorylation in vitro. The effects of one derivative, [4-t-butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03), on stem-cell factor (SCF)/c-kit cellular signaling in 501mel human melanoma cells were examined further. Pretreatment of 501mel cells with ISCK03 inhibited SCF-induced c-kit phosphorylation dose dependently. ISCK03 also inhibited p44/42 ERK mitogen-activated protein kinase (MAPK) phosphorylation, which is known to be involved in SCF/c-kit downstream signaling. However ISCK03 did not inhibit hepatocyte growth factor (HGF)-induced phosphorylation of p44/42 ERK proteins. To determine the in vivo potency of ISCK03, it was orally administered to depilated C57BL/6 mice. Interestingly, oral administration of ISCK03 induced the dose-dependent depigmentation of newly regrown hair, and this was reversed with cessation of ISCK03 treatment. Finally, to investigate whether the inhibitory effect of ISCK03 on SCF/c-kit signaling abolished UV-induced pigmentation, ISCK03 was applied to UV-induced pigmented spots on brownish guinea pig skin. The topical application of ISCK03 promoted the depigmentation of UV-induced hyperpigmented spots. Fontana-Masson staining analysis showed epidermal melanin was diminished in spots treated with ISCK03. These results indicate that phenyl-imidazole sulfonamide derivatives are potent c-kit inhibitors and might be used as skin-whitening agents.


Subject(s)
Imidazoles/pharmacology , Melanins/biosynthesis , Melanoma/metabolism , Proto-Oncogene Proteins c-kit/metabolism , Signal Transduction/drug effects , Sulfonamides/pharmacology , Animals , Cell Line, Tumor , Dose-Response Relationship, Drug , Female , Gene Expression Regulation , Guinea Pigs , Humans , Hyperpigmentation/drug therapy , Imidazoles/chemistry , Mice , Mice, Inbred C57BL , Molecular Structure , Phosphorylation , Sulfonamides/chemistry
12.
J Pharmacol Exp Ther ; 309(1): 71-8, 2004 Apr.
Article in English | MEDLINE | ID: mdl-14718603

ABSTRACT

Transcriptional regulation of the Ig heavy chain gene involves several regulatory elements, including the 3'alpha enhancer, which is composed of four distinct regulatory domains. DNA binding sites for several transcription factors, including B cell-specific activator protein, nuclear factor for immunoglobulin kappa chain in B cells, and octamer have been identified within the 3'alpha enhancer domains and are believed to be important in regulating 3'alpha enhancer activity. We have identified an additional DNA binding motif, the dioxin-responsive element (DRE), which can contribute to 3'alpha enhancer regulation. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), a known disrupter of B cell differentiation (i.e., decreased plasma cell formation, inhibition of micro heavy chain expression, and suppression of IgM secretion), induces binding of the aryl hydrocarbon receptor (AhR) nuclear complex to DREs. TCDD also induces AhR binding to the hypersensitive (hs)4 domain of the 3'alpha enhancer. Interestingly, TCDD enhances LPS-induced activation of the hs4 domain but profoundly inhibits LPS-induced activation of the complete 3'alpha enhancer. Furthermore, site-directed mutational analysis demonstrated that a DRE and kappaB element in the hs4 domain is modulated by TCDD in lipopolysaccharide-activated B cells. We propose that the AhR is a novel transcriptional regulator of the 3'alpha enhancer, which can mediate, at least in part, the effects of TCDD on the 3'alpha enhancer and its domains, putatively contributing to a marked suppression of IgM production.


Subject(s)
Adjuvants, Immunologic/pharmacology , Enhancer Elements, Genetic/drug effects , Gene Expression/drug effects , Immunoglobulin Heavy Chains/metabolism , Polychlorinated Dibenzodioxins/pharmacology , Animals , Cell Line , Immunoglobulin Heavy Chains/genetics , Lipopolysaccharides/pharmacology , Mice , Protein Structure, Tertiary
13.
Toxicol Appl Pharmacol ; 181(2): 69-78, 2002 Jun 01.
Article in English | MEDLINE | ID: mdl-12051990

ABSTRACT

Polychlorinated biphenyls (PCBs) are ubiquitous environmental contaminants and many of their toxic effects, including their immunotoxicities, are mediated by the activation of aryl hydrocarbon receptor (AhR). We previously reported that Aroclor 1254, one of the most widely used PCB mixtures, increased DNA fragmentation in mouse spleen cells, suggesting that apoptosis was correlated with the immunotoxicity of PCB (Yoo et al., Toxicol. Lett. 91, 83-89, 1997). In the present study we investigated the mechanism by which PCB induces apoptosis and the involvement of AhR in the PCB-mediated apoptosis of mouse spleen cells. Aroclor 1254 induced DNA fragmentation without AhR activation, and the apoptosis was unaffected by alpha-naphtoflavone, a well-known antagonist of AhR. Moreover, the PCB congeners (PCB 47, 52, 128, and 153), which have little affinity for AhR, induced DNA fragmentation, whereas congeners (PCB 77, 126, and 169) that have high affinity for AhR did not induce fragmentation. The di-ortho form of PCB (PCB 153) and Aroclor 1254 induced DNA fragmentation in the spleen cells of both AhR knockout mice and Ah low-response mice, whereas the non-ortho form of PCB (PCB 126) did not induce DNA fragmentation. In the light of these findings, it is evident that AhR is not involved in PCB-mediated apoptosis. PCB 153 significantly increased caspase-3 activity in both spleen cells and human leukemia cells, and z-VAD-fmk, a general inhibitor of caspases, prevented PCB-induced DNA fragmentation. Based on our findings, the most likely mechanism that can account for this biological effect involves the induction of caspase-dependent apoptotic cell death.


Subject(s)
Apoptosis/drug effects , Caspases/metabolism , Environmental Pollutants/toxicity , Polychlorinated Biphenyls/toxicity , Receptors, Aryl Hydrocarbon/metabolism , Spleen/drug effects , Animals , Benzoflavones/pharmacology , Caspase 3 , DNA Fragmentation/drug effects , Dose-Response Relationship, Drug , Female , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Knockout , RNA/analysis , Receptors, Aryl Hydrocarbon/genetics , Reverse Transcriptase Polymerase Chain Reaction , Spleen/enzymology , Spleen/pathology
SELECTION OF CITATIONS
SEARCH DETAIL